-+ 0.00%
-+ 0.00%
-+ 0.00%

CRISPR Therapeutics Earnings Report: Q4 Overview

Benzinga·02/12/2026 21:42:08
Listen to the news

The earnings results for CRISPR Therapeutics (NASDAQ:CRSP) for Q4 were made public on Thursday, February 12, 2026 at 04:00 PM.

Here's a comprehensive overview of the announcement.

Earnings

CRISPR Therapeutics missed estimated earnings by -14.17%, reporting an EPS of $-1.37 versus an estimate of $-1.2.

Revenue was down $34.83 million from the same period last year.

Earnings History Overview

The company beat on EPS by $0.13 in the last quarter, resulting in a 1.15% increase share price change the following day.

Here's a look at CRISPR Therapeutics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -1.30 -1.43 -1.25 -1.21
EPS Actual -1.17 -1.29 -1.58 -0.44
Revenue Estimate 8.06M 6.50M 6.39M 7.38M
Revenue Actual 889K 892K 865K 35.69M

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for CRISPR Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.